Skip to content
S8240Senate2021-2022 Session

Free Women's Preventive Care

Official title

“Relates to coverage of primary and preventative obstetric and gynecological care”

Sponsor Cordell CleareSD-30Affects Health
Status
In Senate Committee
Women's Issues
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Women's Issues

What's happening

This bill requires insurance coverage for certain women's health services, including screenings and osteoporosis care, without annual deductibles or coinsurance.

Why it matters

  1. Removes cost barriers to essential women’s health services. by prohibiting insurance plans from requiring annual deductibles and coinsurance for cervical cancer screenings and certain OB/GYN preventive care—potentially increasing access, especially for lower-income women.

  2. Expands the scope of osteoporosis coverage. to include not just detection but also treatment, meaning insurance must cover both diagnosing and managing osteoporosis, which could improve long-term bone health outcomes for at-risk populations.

  3. Aligns insurance standards with federal guidelines. by requiring insurers to adopt criteria from Medicare and the National Institutes of Health when determining coverage for osteoporosis-related services, potentially ensuring evidence-based, up-to-date care is provided.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Free Women's Preventive Care

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Cordell Cleare

Senator · Senate District 30

Chair, Women's Issues

No co-sponsors yet.

History

  1. Referred to women's issues

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8240

IN SENATE

February 7, 2022

Introduced by Sen. CLEARE -- read twice and ordered printed, and when printed to be committed to the Committee on Women's Issues

AN ACT to amend the insurance law, in relation to coverage of primary and preventative obstetric and gynecological care

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subparagraph (C) of paragraph 14 of subsection (l) of section 3221 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:

(C) Such coverage required pursuant to subparagraph (A) or (B) of this paragraph [may] shall not be subject to annual deductibles and coinsurance [as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy].

§ 2. Paragraph 1 of subsection (t) of section 4303 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:

(1) A medical expense indemnity corporation, a hospital service corporation or a health service corporation that provides coverage for hospital, surgical, or medical care shall provide coverage for an annual cervical cytology screening for cervical cancer and its precursor states for women aged eighteen and older. Such coverage required by this paragraph [may] shall not be subject to annual deductibles and coinsurance [as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given contract].

§ 3. The opening paragraph of paragraph 13 of subsection (k) of section 3221 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:

Every group or blanket policy delivered or issued for delivery in this state that provides major medical or similar comprehensive-type coverage shall provide such coverage for bone mineral density measurements or tests, and if such contract otherwise includes coverage for prescription drugs, drugs and devices approved by the federal food and drug administration or generic equivalents as approved substitutes. In determining

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD08660-01-1

appropriate coverage provided by subparagraphs (A), (B) and (C) of this paragraph, the insurer or health maintenance organization shall adopt standards that include the criteria of the federal Medicare program and the criteria of the national institutes of health for the detection and treatment of osteoporosis, provided that such coverage shall be further determined as follows:

§ 4. The opening paragraph of subsection (bb) of section 4303 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:

A health service corporation or a medical service expense indemnity corporation that provides major medical or similar comprehensive-type coverage shall provide such coverage for bone mineral density measurements or tests, and if such contract otherwise includes coverage for prescription drugs, drugs and devices approved by the federal food and drug administration or generic equivalents as approved substitutes. In determining appropriate coverage provided by paragraphs one, two and three of this subsection, the insurer or health maintenance organization shall adopt standards that include the criteria of the federal Medicare program and the criteria of the national institutes of health for the detection and treatment of osteoporosis, provided that such coverage shall be further determined as follows:

§ 5. The second undesignated paragraph of paragraph 26 of subsection (b) of section 4322 of the insurance law, as amended by chapter 219 of the laws of 2011, is amended to read as follows:

In determining appropriate coverage provided by subparagraphs (A), (B) and (C) of this paragraph, the insurer or health maintenance organization shall adopt standards that include the criteria of the federal Medicare program and the criteria of the national institutes of health for the detection and treatment of osteoporosis, provided that such coverage shall be further determined as follows:

§ 6. This act shall take effect on the sixtieth day after it shall have become a law and shall apply to all policies issued, renewed, modified or altered on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to coverage of primary and preventative obstetric and gynecological care

Purpose or general idea of bill

This bill would require insurance coverage for annual cervical cytology screening for cervical cancer without cost sharing and would require insurance coverage for treatment of osteoporosis.

Summary of provisions

The bill amends sections 3221(1) (14) and 4303(t) of the Insurance Law to provide insurance coverage without cost sharing for an annual cervi- cal cytology screening for cervical cancer and its precursor states for women aged 18 and older. Such screenings shall include an annual pelvic examination, collection and preparation of a Pap smear, and laboratory and diagnostic services provided in connection with examining and evalu- ating the Pap smear. The bill also amends § 3221(k)(13), 4303(bb), and 4322 of the Insurance Law to provide insurance coverage for the treat- ment of osteoporosis.

Justification

An annual screening for cervical cancer is essential to ensure prompt treatment of cancer. The current law provides for coverage for these screenings, but authorizes deductibles and coinsurance. The costs asso- ciated with an annual examination results in cases of cervical cancer not being diagnosed until a later stage, which lowers the rate for successful treatment while increasing the costs associated with such treatment. By eliminating the cost-sharing component of an annual cervi- cal cytology screening, the bill would encourage women to undertake annual screenings.

The current law also provides for coverage for bone marrow density meas- urements and other test for the detection of osteoporosis. The bill makes it clear that such policies would also be required to provide coverage for the treatment of osteoporosis.

Prior legislative history

2019-2020: A.6481 - referred to Insurance

Fiscal implications for state and local governments

None.

Effective date

This act shall take effect on the sixtieth day after it shall have become a law and shall apply to all policies, issued, renewed, modified or altered on or after such date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.